J Greg Murison

Title: J Greg Murison: Innovator in Immune Response Enhancement

Introduction

J Greg Murison is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of immunology through his innovative research and patenting efforts. His work focuses on enhancing immune responses, which has important implications for treating various diseases.

Latest Patents

Murison holds a patent titled "Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides." This patent includes isolated fibroblast growth factor receptor (FGFR5) polypeptides and polynucleotides encoding such polypeptides. The patent also covers modulators of FGFR5 gene expression and binding molecules that specifically bind to and modulate FGFR5 polypeptide function. These specific binding molecules include antibodies and functional fragments, as well as scFv and Camelidae heavy chain IgG. The innovations presented in this patent are effective agents suitable for treating diseases such as osteopontin-mediated autoimmune diseases, bone disorders, and various cancers.

Career Highlights

J Greg Murison is associated with Genesis Research & Development Corporation Limited, where he continues to advance his research in immunology. His work has garnered attention for its potential to improve therapeutic strategies for complex diseases.

Collaborations

Murison collaborates with Matthew Sleeman, contributing to the innovative research environment at Genesis Research & Development Corporation Limited.

Conclusion

J Greg Murison's contributions to the field of immunology through his patent on FGFR5 polypeptides highlight his role as an important inventor in enhancing immune responses. His work has the potential to lead to significant advancements in the treatment of various diseases.